| Primary |
| Neuromuscular Blockade Reversal |
22.7% |
| Drug Use For Unknown Indication |
13.6% |
| Induction Of Anaesthesia |
13.6% |
| Abdominal Distension |
6.8% |
| Ileus |
6.8% |
| Adverse Event |
4.5% |
| Prophylaxis |
4.5% |
| Anaesthesia Reversal |
2.3% |
| Colonic Pseudo-obstruction |
2.3% |
| General Anaesthesia |
2.3% |
| Haemorrhage Prophylaxis |
2.3% |
| Hypertension |
2.3% |
| Infection Prophylaxis |
2.3% |
| Intestinal Functional Disorder |
2.3% |
| Intestinal Obstruction |
2.3% |
| Neurogenic Bowel |
2.3% |
| Obstruction |
2.3% |
| Prophylaxis Of Nausea And Vomiting |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
|
| Tachycardia |
18.2% |
| Drug Ineffective |
9.1% |
| Medication Error |
9.1% |
| Respiratory Arrest |
9.1% |
| Bronchospasm |
4.5% |
| Coagulopathy |
4.5% |
| Electromechanical Dissociation |
4.5% |
| Heart Rate Increased |
4.5% |
| Hyperhidrosis |
4.5% |
| Large Intestine Perforation |
4.5% |
| Muscular Weakness |
4.5% |
| Pancreatitis |
4.5% |
| Procedural Complication |
4.5% |
| Urticaria |
4.5% |
| Wound Infection |
4.5% |
| Wrong Drug Administered |
4.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.4% |
| Anaesthesia |
17.9% |
| Product Used For Unknown Indication |
12.3% |
| Anaesthesia Procedure |
6.1% |
| General Anaesthesia |
5.2% |
| Neuromuscular Blockade Reversal |
4.5% |
| Maintenance Of Anaesthesia |
4.2% |
| Induction Of Anaesthesia |
4.0% |
| Hypertension |
2.5% |
| Sedation |
2.5% |
| Anaesthesia Reversal |
2.3% |
| Blood Pressure Increased |
2.2% |
| Premedication |
1.8% |
| Neuromuscular Blockade |
1.6% |
| Prophylaxis |
1.6% |
| Vitamin Supplementation |
1.6% |
| Hypotension |
1.4% |
| Tachycardia |
1.4% |
| Endotracheal Intubation |
1.3% |
| Atrial Fibrillation |
1.1% |
|
| Cardiac Arrest |
15.3% |
| Toxic Epidermal Necrolysis |
8.5% |
| Conversion Disorder |
6.8% |
| Tachycardia |
6.8% |
| Tachypnoea |
6.8% |
| Completed Suicide |
5.1% |
| Drug Interaction |
5.1% |
| Renal Failure Acute |
5.1% |
| Serotonin Syndrome |
5.1% |
| Chylothorax |
3.4% |
| Electrocardiogram St Segment Elevation |
3.4% |
| Laryngeal Oedema |
3.4% |
| Laryngospasm |
3.4% |
| Oxygen Saturation Decreased |
3.4% |
| Product Deposit |
3.4% |
| Torsade De Pointes |
3.4% |
| Unresponsive To Stimuli |
3.4% |
| Ventricular Tachycardia |
3.4% |
| Wound Infection |
3.4% |
| Acute Respiratory Distress Syndrome |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.2% |
| Product Used For Unknown Indication |
15.3% |
| Anaesthesia |
9.1% |
| Pain |
5.3% |
| Induction Of Anaesthesia |
4.7% |
| Hypertension |
4.6% |
| General Anaesthesia |
4.3% |
| Supplementation Therapy |
3.9% |
| Maintenance Of Anaesthesia |
3.3% |
| Sedation |
2.8% |
| Psoas Abscess |
2.7% |
| Neuromuscular Blockade Reversal |
2.5% |
| Thrombosis Prophylaxis |
2.3% |
| Acute Coronary Syndrome |
2.0% |
| Premedication |
1.9% |
| Intraoperative Care |
1.7% |
| Anaesthesia Reversal |
1.5% |
| Epilepsy |
1.4% |
| Antibiotic Prophylaxis |
1.4% |
| Catheterisation Cardiac |
1.3% |
|
| Tremor |
9.5% |
| Unresponsive To Stimuli |
7.1% |
| Vomiting |
7.1% |
| Respiratory Disorder |
6.3% |
| Septic Shock |
6.3% |
| Thrombocytopenia |
6.3% |
| Pulmonary Embolism |
5.6% |
| Serotonin Syndrome |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Post Procedural Complication |
4.8% |
| Upper Respiratory Tract Infection |
4.8% |
| Fatigue |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Tongue Oedema |
4.0% |
| Dystonia |
3.2% |
| Neuromuscular Block Prolonged |
3.2% |
| Renal Failure Acute |
3.2% |
| Skin Ulcer |
3.2% |
| Somnolence |
3.2% |
| Swollen Tongue |
3.2% |
|
| Interacting |
| Anaesthesia Procedure |
47.4% |
| Induction Of Anaesthesia |
26.3% |
| Product Used For Unknown Indication |
21.1% |
| Benign Prostatic Hyperplasia |
5.3% |
|
| Atrioventricular Dissociation |
33.3% |
| Drug Interaction |
33.3% |
| Unwanted Awareness During Anaesthesia |
33.3% |
|
